Editor of Patient Care Online.
Aspirin Use among Older Adults Inconsistent with Current Guidelines, According to New Survey
In a survey of adults aged 50-80 years, 57% of those who reported taking aspirin regularly said they do not have a history of CVD.
In Pregnant Women with T1D, Higher Time-in-Range Improves Maternal, Neonatal Outcomes: Daily Dose
Your daily dose of the clinical news you may have missed.
First Issue of Patient Care Online Digital Edition Goes Live
The inaugural digital issue of Patient Care focuses on the antiobesity and type 2 diabetes medications, semaglutide and tirzepatide.
Early Detection of CKD Progression in Primary Care: Daily Dose
Nirsevimab 90% Effective Against RSV Hospitalization among Infants, According to New CDC Data
Findings support current CDC recommendations that all infants should be protected by maternal RSV vaccination or infant receipt of nirsevimab.
Semaglutide Lowers CKD-Related Events in Persons with T2D, CKD: Daily Dose
New Data Show High Prevalence of Dyslipidemia in American Indian Youth
Few participants with dyslipidemia received lipid-lowering medications despite high prevalence, reported authors of the Strong Family Heart Study.
Migraine, Persistent VMS Tied to Higher Risk of CVD, Stroke: Daily Dose
Plastic Debris Detected in Carotid Plaque Linked to Higher Risk for MI, Stroke, Death
Patients who had microplastics and nanoplastics in their carotid plaque were at more than a fourfold risk for MI, stroke, or death compared to those who did not, according to a new study.
Neffy May be Safe, Effective for Treatment of Urticaria Flares: Daily Dose
Semaglutide Shows Potential for Significant CVD Prevention: Daily Dose
CDC: Persons with COVID-19, Flu, RSV, Other Respiratory Viruses No Longer Have to Isolate for 5 Days
The updated guidelines reflect the progress made in protecting against severe illness from COVID-19, said CDC Director Mandy Cohen, MD, MPH.
Cannabis Use Associated with Higher Risk of MI, Stroke: Daily Dose
Phase 3 Findings on Neffy for Pediatric Patients with Severe Allergies: A Conversation with Motohiro Ebisawa, MD, PhD
Dr Ebisawa details the findings he recently presented at the 2024 AAAAI annual meeting, including adverse events and next steps for the study.
Atogepant Safe, Effective in Treatment-Resistant Episodic Migraine: Daily Dose
Migraine and Persistent Vasomotor Symptoms Linked to Higher Risk of CVD, Stroke in Analysis of CARDIA Study
Women with migraine and persistent VMS faced double the risk of CVD and triple the risk of stroke, reported researchers.
Women with IBD at Risk for Reduced Fertility: Daily Dose
State of US Mental Health: Happiest Cities in 2024
Which city has the highest depression rate? Or the fewest work hours? Find the answers and more insights from a nationwide analysis, here.
Marijuana Use Linked to Higher Risk of Myocardial Infarction, Stroke in New Study
The risk for cardiovascular outcomes increased with more frequent reported cannabis use per month, according to results from a large national study.
Dupilumab Plus Medium-Dose Inhaled Corticosteroid Improves Lung Function, Asthma Control: Daily Dose
Salt Substitute Reduces HTN Risk among Older Adults with Normal BP: Daily Dose
New Data Suggest neffy May be Safe, Effective for Treatment of Urticaria Flares
AAAAI 2024. In patients with treatment-resistant chronic spontaneous urticaria, neffy 1 mg and 2 mg resulted in improvement in itch, hives, urticaria, and erythema scores 5 minutes after dosing.
Impact of Regular Exercise on Hospitalization in Patients with COPD: Daily Dose
Ethnic Minorities Found More Likely to Require Change in Biologic Therapy for Severe Asthma
New data presented at AAAAI 2024 sheds light on real-world patterns of biologic use in a diverse patient population with severe asthma.
Lowering Out-of-Pocket Rx Costs May Improve Diabetes Outcomes: Daily Dose
New Research Highlights Specific Allergens that May Predispose Sensitized Children with Asthma to Upper Respiratory Infections
AAAAI 2024. Indoor mouse and cockroach, but not cat and dog, allergen exposure were associated with URI outcomes among children with asthma.
Weight Management Treatments Underused among Primary Care Patients with Obesity: Daily Dose
Dupilumab Plus Medium-Dose Inhaled Corticosteroid Improved Lung Function and Asthma Control, According to New Data
AAAAI 2024. Patients with asthma who received dupilumab plus medium-dose ICS had improved lung function and asthma control vs those who received placebo plus high-dose ICS.
Tighter Glycemic Control in T2D Reduces Risk for All-Cause Dementia: Daily Dose
Salt Substitute Lowers Risk of Hypertension among Older Adults with Normal Blood Pressure
Older adults with normal BP levels in China were approximately 40% less likely to develop HTN when using a salt substitute for 2 years, according to a new study.
